IL178827A0 - Use of reboxetine for the treatment of pain - Google Patents

Use of reboxetine for the treatment of pain

Info

Publication number
IL178827A0
IL178827A0 IL178827A IL17882706A IL178827A0 IL 178827 A0 IL178827 A0 IL 178827A0 IL 178827 A IL178827 A IL 178827A IL 17882706 A IL17882706 A IL 17882706A IL 178827 A0 IL178827 A0 IL 178827A0
Authority
IL
Israel
Prior art keywords
reboxetine
pain
treatment
Prior art date
Application number
IL178827A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0412878A external-priority patent/GB0412878D0/en
Priority claimed from GB0425061A external-priority patent/GB0425061D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of IL178827A0 publication Critical patent/IL178827A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL178827A 2004-06-09 2006-10-23 Use of reboxetine for the treatment of pain IL178827A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0412878A GB0412878D0 (en) 2004-06-09 2004-06-09 Use
US58865204P 2004-07-16 2004-07-16
GB0425061A GB0425061D0 (en) 2004-11-12 2004-11-12 Use
US63442704P 2004-12-07 2004-12-07
PCT/IB2005/001904 WO2006000903A2 (en) 2004-06-09 2005-05-27 Use of reboxetine for the treatment of pain

Publications (1)

Publication Number Publication Date
IL178827A0 true IL178827A0 (en) 2007-03-08

Family

ID=34979099

Family Applications (1)

Application Number Title Priority Date Filing Date
IL178827A IL178827A0 (en) 2004-06-09 2006-10-23 Use of reboxetine for the treatment of pain

Country Status (12)

Country Link
US (1) US20080261984A1 (enExample)
EP (1) EP1763354A2 (enExample)
JP (1) JP2008501778A (enExample)
KR (1) KR20070029740A (enExample)
AU (1) AU2005256944A1 (enExample)
BR (1) BRPI0511941A (enExample)
CA (1) CA2567365A1 (enExample)
IL (1) IL178827A0 (enExample)
MX (1) MXPA06014389A (enExample)
NO (1) NO20064642L (enExample)
RU (1) RU2006143659A (enExample)
WO (1) WO2006000903A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090233959A1 (en) 2008-02-19 2009-09-17 Adolor Corporation Beloxepin and analogs for the treatment of pain
US20130310385A1 (en) * 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US9320725B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
US9345689B2 (en) 2012-05-18 2016-05-24 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N, N-dimethyl-4-phenyl-4,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and an anticonvulsant
EP3782627A4 (en) * 2018-04-17 2021-07-07 Shanghai Tonglian Pharmaceutical Co., Ltd. MEDICINAL PRODUCT USED TO PREVENT AND / OR TREAT PAIN AND / OR FEVER, A COMBINATION PRODUCT, AND USE OF THEM
WO2019222850A1 (en) * 2018-05-23 2019-11-28 Wex Pharmaceuticals Inc. Synergistic tetrodotoxin formulations and methods of treatment for neuropathic pain
WO2019245975A1 (en) * 2018-06-17 2019-12-26 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
US11020402B2 (en) 2018-10-15 2021-06-01 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia
BR112021007019A2 (pt) * 2018-10-15 2021-07-13 Axsome Therapeutics, Inc. uso de reboxetina para tratar narcolepsia
US12616702B2 (en) * 2019-12-03 2026-05-05 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy
CR20220247A (es) * 2019-12-03 2022-08-18 Axsome Therapeutics Inc Uso de reboxetina para tratar los trastornos del sistema nervioso
US20260174699A1 (en) * 2024-12-23 2026-06-25 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising uniform blends of reboxetine
US12565478B1 (en) 2025-01-21 2026-03-03 Axsome Therapeutics, Inc. (S)-2-((S)-(2-ethoxyphenoxy)(phenyl)methyl)-4-nitrosomorpholine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US422449A (en) * 1890-03-04 Gage for gas-cocks
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
ATE305788T1 (de) * 1999-07-01 2005-10-15 Pharmacia & Upjohn Co Llc (s,s)-reboxetin zur behandlung von inkontinenz
SI1196172T1 (sl) * 1999-07-01 2006-06-30 Pharmacia & Upjohn Co Llc (S,S)-reboksetin za zdravljenje kronicne bolecine
US20040204411A1 (en) * 2002-12-17 2004-10-14 Pharmacia Corporation Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof
MXPA06002778A (es) * 2003-09-09 2006-06-14 Pfizer Prod Inc Combinacion de inhibidores de recaptacion de serotonina e inhibidores de recaptacion de norepinefrina.
ATE449633T1 (de) * 2003-09-12 2009-12-15 Pfizer Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern

Also Published As

Publication number Publication date
US20080261984A1 (en) 2008-10-23
MXPA06014389A (es) 2007-02-19
AU2005256944A1 (en) 2006-01-05
WO2006000903A2 (en) 2006-01-05
CA2567365A1 (en) 2006-01-05
WO2006000903A3 (en) 2006-06-08
NO20064642L (no) 2006-11-13
EP1763354A2 (en) 2007-03-21
RU2006143659A (ru) 2008-06-20
JP2008501778A (ja) 2008-01-24
KR20070029740A (ko) 2007-03-14
BRPI0511941A (pt) 2008-01-22

Similar Documents

Publication Publication Date Title
GB0403969D0 (en) Tissue treatment device
EP1731113A4 (en) MEDICAL TREATMENT KIT
EP1809265A4 (en) Methods for the treatment of synucleinopathies
IL187405A0 (en) Methods and compositions for the treatment of pain
GB0415181D0 (en) Compounds for use in the treatment of infection
GB0425854D0 (en) Therapeutic treatment
GB0300428D0 (en) Medical treatment
IL178907A0 (en) Use of sulglicotide for the treatment of mucositis
GB0419828D0 (en) The treatment of inflammatroy disorders and pain
GB0408752D0 (en) Therapeutic treatment
GB2419532B (en) Skin treatment device
GB0701549D0 (en) Skin treatment
GB0415267D0 (en) The treatment of pain
GB0418556D0 (en) The treatment of pain
ZA200710476B (en) Methods and compositions for the treatment of pain
ZA200704046B (en) Treatment of burns
GB0412262D0 (en) Use of compounds for the treatment of pain
GB0306165D0 (en) Medical treatment
GB0325957D0 (en) The treatment of pain
GB0322014D0 (en) The treatment of pain
GB0415318D0 (en) Medical treatment
GB0419703D0 (en) Medical treatment
GB0401792D0 (en) Medical treatment
GB0401807D0 (en) Medical treatment
GB0404339D0 (en) Therapeutic treatment